Danaher (DHR) insider buying

Healthcare · Diagnostics & Research · Market cap $151.8B

12 open-market purchases of DHR by Danaher's executives and directors since September 2025, worth $0 in total, from SEC Form 4 filings.

The most recent: Ro Khanna bought — on March 10, 2026.

The biggest buyer over the period is Ro Khanna: 6 purchases, $0.

By year

YearPurchasesValue
20262$0
202510$0

Biggest buyers

InsiderBuysValue
Ro Khanna
6$0
Julie Johnson
2$0
Michael T. Mccaul
4$0

Every purchase

Newest first. From SEC Form 4 filings. Insider buying across the market.

DateInsiderSharesPriceValueFiling
Mar 10, 2026 Ro Khanna
0$195.32— —
Mar 10, 2026 Ro Khanna
0$195.32— —
Nov 3, 2025 Ro Khanna
0$214.10— —
Nov 3, 2025 Ro Khanna
0$214.10— —
Oct 7, 2025 Julie Johnson
0$208.63— —
Oct 7, 2025 Julie Johnson
0$208.63— —
Oct 3, 2025 Ro Khanna
0$215.05— —
Oct 3, 2025 Ro Khanna
0$215.05— —
Sep 25, 2025 Michael T. Mccaul
0$181.56— —
Sep 25, 2025 Michael T. Mccaul
0$181.56— —
Sep 9, 2025 Michael T. Mccaul
0$194.24— —
Sep 9, 2025 Michael T. Mccaul
0$194.24— —
Every line, every quarterThe deep dive has fifteen-plus years of statements, quarterly results, charts and valuation models for DHR.
Open DHR in Investingly

Questions

Are Danaher insiders buying the stock?

12 open-market purchases of DHR by Danaher's executives and directors since September 2025, worth $0 in total, from SEC Form 4 filings. The most recent: Ro Khanna bought — on March 10, 2026.

What counts as insider buying here?

Open-market purchases (Form 4 code P) by officers and directors. Option exercises, grants and purchases by 10% owners are left out.

From Danaher's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.